Other research highlights: 30% of GLP-1 users tested positive for SIBO or IMO even after accounting for diabetes (5) GLP-1 medicines caused microbiome changes and altered metabolism in mice (6) GLP-1 medicines tested in humans only had noticeable microbiome changes by 48 weeks (7) Despite not necessarily having slower gut motility, one study found that 88.9% of obese patients had SIBO (8) A meta analysis of people with IBS symptoms, found that up to 78% of people had SIBO, many of whom were undiagnosed (9) Overall, Sun and colleagues (1) could not prove a mechanistic link between GLP-1 medications and SIBO, however they did find that SIBO was twice as likely in GLP-1 users
Converting it to an injectable solution requires bacteriostatic water and careful technique
Huntsvilles deep scientific talent, advanced manufacturing strengths, and ready infrastructure made it the clear choice for this investment. Major Economic and Workforce Impact Construction on the facility is expected to begin in 2026 , supporting approximately 3,000 construction jobs , with operations projected to come online by 2032
Free of Gluten, Wheat, Yeast, Sugar, Salt, Artificial Flavors, Artificial Sweeteners, Artificial Preservatives, Artificial Colors ADDITIONAL Solgar Acetyl INFORMATION Warnings If you are pregnant, nursing, taking any medications or have any medical condition, please consult your healthcare practitioner before taking any dietary supplement